Literature DB >> 6874906

Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.

D A Preston, R N Jones, A L Barry, C Thornsberry.   

Abstract

The validity of the class representative concept for in vitro susceptibility testing of older cephalosporins was reevaluated. Two oral cephalosporins, cephalexin and cefaclor, were compared with the established cephalosporin class representative, cephalothin, by using reference microdilution minimal inhibitory concentrations of 528 isolates of a wide variety of gram-positive and gram-negative bacterial pathogens. For each comparison, there were only 15 (2.8%) random major and very major interpretive discrepancies. Additional comparisons confirmed the need to test second-generation (cefamandole) and third-generation (cefotaxime) cephalosporins separately. These results provide reasonable assurance that the use of cephalothin as an in vitro predictor of qualitative bacterial susceptibility to these two oral cephalosporins remains an acceptable alternative to testing each antibiotic individually.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874906      PMCID: PMC272818          DOI: 10.1128/jcm.17.6.1156-1158.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  In vitro antimicrobial activity comparison of cefaclor (compound 99638), cephradine, and cephalothin.

Authors:  R N Jones; E H Gerlach; P C Fuchs
Journal:  J Antibiot (Tokyo)       Date:  1977-09       Impact factor: 2.649

2.  Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing.

Authors:  A L Barry; D L Draper; M K Wong
Journal:  Am J Clin Pathol       Date:  1978-11       Impact factor: 2.493

3.  Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.

Authors:  R N Jones; P C Fuchs; C Thornsberry; A L Barry; T L Gavan; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1979-10       Impact factor: 2.493

4.  Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.

Authors:  A L Barry; C Thornsberry; R N Jones; P C Fuchs; T L Gavan; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1978-12       Impact factor: 2.493

5.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

  5 in total
  8 in total

1.  Comparison of cefadroxil and cephalothin disk susceptibility test results.

Authors:  A L Barry; R N Jones
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

2.  Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.

Authors:  R N Jones; P C Fuchs; A L Barry; L W Ayers; E H Gerlach; T L Gavan
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

3.  Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

4.  Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.

Authors:  R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

5.  Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807).

Authors:  R N Jones; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

6.  Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines.

Authors:  R N Jones; A L Barry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

7.  Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.

Authors:  R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

8.  LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks.

Authors:  R N Jones; C Baker; A L Barry; P C Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.